Fischer Jens W, Schrör Karsten
Institut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Thromb Haemost. 2007 Aug;98(2):287-95.
Hyaluronan (HA) is a macromolecular polysaccharide of the vascular extracellular matrix that confers both structural functions as well as signalling activity. HA is involved in a wide variety of biological processes, such as tissue morphogenesis, malignant growth and metastasis, wound healing and angiogenesis. In atherosclerosis, HA associates with leukocytes and vascular smooth muscle cells (VSMC) and is involved in vascular remodelling. HA is synthesized at the plasma membrane by three HA-synthase isoforms (HAS1-3). Human VSMC upregulate HAS1 and HAS2 in response to prostaglandins via Gs-coupled prostaglandin receptor subtypes IP and EP2. This review discusses the regulation of HA-synthesis by prostaglandins and the evidence for a central role of cyclooxygenase-2/PGE2 in regulation of HA-synthesis during atherogenesis.
透明质酸(HA)是血管细胞外基质的一种大分子多糖,它兼具结构功能和信号传导活性。HA参与多种生物学过程,如组织形态发生、恶性生长与转移、伤口愈合及血管生成。在动脉粥样硬化中,HA与白细胞和血管平滑肌细胞(VSMC)相关联,并参与血管重塑。HA由三种透明质酸合酶亚型(HAS1 - 3)在质膜上合成。人类血管平滑肌细胞通过Gs偶联的前列腺素受体亚型IP和EP2对前列腺素作出反应,上调HAS1和HAS2。本综述讨论了前列腺素对HA合成的调节作用,以及环氧化酶 - 2 / PGE2在动脉粥样硬化形成过程中对HA合成调节起核心作用的证据。